IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Medicxi Ventures Management (Jersey) Ltd

Q2 2024 Holdings

Filed 2024-07-16 | 4 holdings | $335.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$180.3M19,963,15753.8%
Phathom Pharmaceuticals Inc(PHAT)COM71722W107$76.9M7,464,57222.9%
Newamsterdam Pharma Company(NAMS)ORDINARY SHARESN62509109$55.1M2,869,56516.4%
Aura Biosciences Inc(AURA)COM05153U107$23.0M3,039,8926.9%